DI-054 Safety results of direct acting antivirals for the treatment of hepatitis C virus infection
DI-054 Safety results of direct acting antivirals for the treatment of hepatitis C virus infection
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
BackgroundThe recent development of new drugs has changed radically the treatment of chronic hepatitis C virus (HCV) infection, from interferon (IFN) based treatments to treatments based on direct acting antivirals (DAA). These drugs are thought to be better tolerated but data are still preliminary.PurposeThe aim of this study was to evaluate the s...
Alternative Titles
Full title
DI-054 Safety results of direct acting antivirals for the treatment of hepatitis C virus infection
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2552749153
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2552749153
Other Identifiers
ISSN
2047-9956
E-ISSN
2047-9964
DOI
10.1136/ejhpharm-2016-000875.320
